AFF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.01290000054099E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.6310999984579E-08 |
Normal-vs-Stage2 |
2.083800E-03 |
Normal-vs-Stage3 |
1.712450E-02 |
Normal-vs-Stage4 |
3.939800E-01 |
Stage1-vs-Stage2 |
1.737160E-01 |
Stage1-vs-Stage3 |
1.661240E-01 |
Stage1-vs-Stage4 |
3.903600E-01 |
Stage2-vs-Stage3 |
8.695800E-01 |
Stage2-vs-Stage4 |
7.281600E-01 |
Stage3-vs-Stage4 |
7.597600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.48170000397508E-08 |
Normal-vs-AfricanAmerican |
7.55700000000248E-05 |
Normal-vs-Asian |
6.472400E-01 |
Caucasian-vs-AfricanAmerican |
5.807200E-01 |
Caucasian-vs-Asian |
1.610640E-01 |
AfricanAmerican-vs-Asian |
2.442800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.3087999007364E-10 |
Normal-vs-Female |
1.496070E-02 |
Male-vs-Female |
7.578300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.800600E-04 |
Normal-vs-Extreme_Weight |
1.03340003221319E-09 |
Normal-vs-Obese |
5.64779999999709E-05 |
Normal-vs-Extreme_Obese |
5.86870000000017E-05 |
Normal_Weight-vs-Extreme_Weight |
1.458230E-01 |
Normal_Weight-vs-Obese |
7.627400E-01 |
Normal_Weight-vs-Extreme_Obese |
3.333800E-01 |
Extreme_Weight-vs-Obese |
2.075900E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.809400E-01 |
Obese-vs-Extreme_Obese |
1.439620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.928600E-01 |
Normal-vs-Age(41-60Yrs) |
2.26839999994954E-06 |
Normal-vs-Age(61-80Yrs) |
5.07270000449367E-08 |
Normal-vs-Age(81-100Yrs) |
4.01680000039484E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.701600E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.499800E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.282380E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.287200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.896000E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.483800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
3.56240004162345E-09 |
Normal-VS-Type2 PRCC |
1.52817999999888E-05 |
Normal-VS-KIRP CIMP |
4.720600E-01 |
Normal-VS-Unclassified PRCC |
1.683730E-03 |
Type1 PRCC-VS-Type2 PRCC |
4.679800E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.339600E-02 |
Type1 PRCC-VS-Unclassified PRCC |
3.390500E-02 |
Type2 PRCC-VS-KIRP CIMP |
5.758400E-02 |
Type2 PRCC-VS-Unclassified PRCC |
1.991010E-01 |
KIRP CIMP-VS-Unclassified PRCC |
1.089810E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.32389999996096E-06 |
Normal-vs-N1 |
3.461600E-01 |
Normal-vs-N2 |
9.844400E-01 |
N0-vs-N1 |
4.302300E-02 |
N0-vs-N2 |
5.338600E-01 |
N1-vs-N2 |
7.534800E-01 |
|
|